Robert Lorne Abel - 21 Jun 2021 Form 4 Insider Report for Schrodinger, Inc. (SDGR)

Role
EVP, Chief Computational Scientist, Head of Modeling R&D
Signature
/s/ Donald Shum, as attorney-in-fact for Robert Lorne Abel
Issuer symbol
SDGR
Transactions as of
21 Jun 2021
Net transactions value
-$993,557
Form type
4
Filing time
22 Jun 2021, 17:00:50 UTC
Previous filing
07 May 2021
Next filing
14 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SDGR Common Stock Options Exercise $132,838 +7,814 $17.00 7,814 21 Jun 2021 Direct F1
transaction SDGR Common Stock Options Exercise $24,191 +5,574 +71% $4.34* 13,388 21 Jun 2021 Direct F1
transaction SDGR Common Stock Options Exercise $6,465 +2,214 +17% $2.92* 15,602 21 Jun 2021 Direct F1
transaction SDGR Common Stock Sale $1,157,051 -15,602 -100% $74.16 0 21 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SDGR Stock Option (right to buy) Options Exercise $0 -2,214 -100% $0.000000* 0 21 Jun 2021 Common Stock 2,214 $2.92 Direct F1, F2
transaction SDGR Stock Option (right to buy) Options Exercise $0 -5,574 -33% $0.000000 11,148 21 Jun 2021 Common Stock 5,574 $4.34 Direct F1, F3
transaction SDGR Stock Option (right to buy) Options Exercise $0 -7,814 -5.8% $0.000000 125,959 21 Jun 2021 Common Stock 7,814 $17.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
F2 The option was granted on June 1, 2017 and is fully vested.
F3 This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.
F4 This option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

Remarks:

EVP, Chief Computational Scientist, Head of Modeling R&D